While little-known on Wall Street, Kennesaw, Georgia based CryoLife (NYSE:CRY), a reputable name in the medical equipment sector, could soon win more attention from investors. The company is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the U.S., Canada and some countries in Europe.
CryoLife is a cash-rich and debt-free company with a market cap of $176 million. As of March 31, 2013, CryoLife had 13.9 million in cash and cash equivalents on its book. Recently the company raised its quarterly cash dividend by 10% for the second quarter of 2013. The company's earnings are expected to increase substantially going forward. In this article I'll dig...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|